131 related articles for article (PubMed ID: 2645176)
1. Primary central nervous system lymphoma: long-term survival following treatment with radiation and methotrexate.
Petursson SR
Eur J Surg Oncol; 1989 Feb; 15(1):69-72. PubMed ID: 2645176
[TBL] [Abstract][Full Text] [Related]
2. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
Higuchi M; Hata T; Furuya S; Hosaka S; Kamijo Y; Kiyosawa K; Ishizuka O; Nishizawa O; Hora K
Nephrology (Carlton); 2005 Jun; 10(3):321-4. PubMed ID: 15958050
[TBL] [Abstract][Full Text] [Related]
5. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
6. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
Weigel R; Senn P; Weis J; Krauss JK
Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
[TBL] [Abstract][Full Text] [Related]
7. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic problems in case of primary central nervous system lymphoma].
Dubik-Jezierzańska M; Pokryszko-Dragan A; Turek T; Budrewicz S; Pawlik B
Wiad Lek; 2006; 59(7-8):552-6. PubMed ID: 17209358
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of primary cerebral lymphoma].
Delwail V; Bataille B
Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
[TBL] [Abstract][Full Text] [Related]
10. [Primary spinal intramedullary malignant lymphoma: case report].
Nakao K; Waga S; Sakaida H; Sakakura M; Tocho H; Ohno H; Miyazaki M
No Shinkei Geka; 1994 Jun; 22(6):583-7. PubMed ID: 8015682
[TBL] [Abstract][Full Text] [Related]
11. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
12. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K
Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485
[TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Laack NN; Ballman KV; Brown PB; O'Neill BP;
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1429-39. PubMed ID: 16863926
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
[TBL] [Abstract][Full Text] [Related]
16. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.
McAllister LD; Doolittle ND; Guastadisegni PE; Kraemer DF; Lacy CA; Crossen JR; Neuwelt EA
Neurosurgery; 2000 Jan; 46(1):51-60; discussion 60-1. PubMed ID: 10626935
[TBL] [Abstract][Full Text] [Related]
17. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Herrlinger U; Küker W; Uhl M; Blaicher HP; Karnath HO; Kanz L; Bamberg M; Weller M;
Ann Neurol; 2005 Jun; 57(6):843-7. PubMed ID: 15929034
[TBL] [Abstract][Full Text] [Related]
18. [Cauda equina syndrome due to recurrent malignant lymphoma of the spinal cord. A case report].
Miyata E; Koga H; Yamamoto H; Okamoto M; Hirano M
Rinsho Shinkeigaku; 1999 Oct; 39(10):1071-4. PubMed ID: 10655773
[TBL] [Abstract][Full Text] [Related]
19. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
